Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BRNSBRNS
Showing 8 of 11 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BARINTHUS BIOTHERAPEUTICS PL

No. Geode Capital Management exited its BRNS (Barinthus Biotherapeutics PL) position in Q2 2026. Its Q1 2026 13F listed 11,568 shares worth $6,622. Geode Capital Management first reported BRNS in Q4 2023 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$14,228

Total Shares Change

-11,568

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.66
0
2026-Q1
Unchanged
11,568
0.0%
$6,6220.0%$0.60
0
2025-Q4
Unchanged
11,568
0.0%
$8,0980.0%$0.68
0
2025-Q3
Unchanged
11,568
0.0%
$14,4600.0%$1.48
0
2025-Q2
Unchanged
11,568
0.0%
$10,5290.0%$0.92
0
2025-Q1
Unchanged
11,568
0.0%
$11,4520.0%$1.05
0
2024-Q4
Unchanged
11,568
0.0%
$13,8810.0%$1.10
0
2024-Q3
Unchanged
11,568
0.0%
$14,2280.0%$1.18
0

Other major holders of BRNS: Alphabet Inc., M&G Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used